Researchers at The University of Texas MD Anderson Cancer Center have identified an epigenetic target for replication stress, ...

A cancer drug target already being investigated in clinical trials turns out to be doing something even more consequential ...

Drug resistance remains a central barrier to durable responses across cancer therapies, spanning targeted agents, cytotoxic chemotherapy, endocrine ...

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare ...

In December, The Conversation hosted a webinar on AI's revolutionary role in drug discovery and development. Science and ...